Oculis Holding AG (OCS) Total Liabilities (2021 - 2026)
Oculis Holding AG (OCS) posted quarterly Total Liabilities of $60.5 million for Q1 2026, up 30.84% year-over-year from $46.2 million in Q1 2025, and up 21.13% quarter-over-quarter from $49.9 million in Q4 2025.
Oculis Holding AG (OCS) Total Liabilities (2021 - 2026) Analysis & Trends
Oculis Holding AG's Total Liabilities history runs 6 years deep, the most recent figure standing at $60.5 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 30.84% year-over-year to $60.5 million; the TTM figure through Mar 2026 stood at $60.5 million (up 30.84% YoY), while the FY2025 annual figure was $48.1 million, down 9.88% from the prior year.
- Total Liabilities for Q1 2026 stood at $60.5 million, up from $49.9 million in the prior quarter.
- The five-year high for Total Liabilities was $140.2 million in Q4 2022, with the low at $19.6 million in Q2 2023.
- The 5-year median for Total Liabilities is $46.2 million (2025), against an average of $46.1 million.
- The sharpest annual moves came in 2023 and 2024: Total Liabilities tumbled 83.41% in 2023, then surged 130.6% in 2024.
- Oculis Holding AG's Total Liabilities stood at $140.2 million in 2022, then slumped by 83.41% to $23.3 million in 2023, then soared by 130.6% to $53.6 million in 2024, then retreated by 6.91% to $49.9 million in 2025, then gained by 21.13% to $60.5 million in 2026.
- Business Quant data shows OCS's Total Liabilities at $60.5 million in Q1 2026, $49.9 million in Q4 2025, and $46.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Oculis Holding AG | 879.09 Mn | 590.21 Mn | - | 39.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.22 Mn |
| Mar 31, 2026 | 60.46 Mn |
| Dec 31, 2025 | 49.91 Mn |
| Sep 30, 2025 | 46.56 Mn |
| Jun 30, 2025 | 46.53 Mn |
| Mar 31, 2025 | 46.21 Mn |
| Dec 31, 2024 | 53.62 Mn |
| Sep 30, 2024 | 35.06 Mn |
| Jun 30, 2024 | 28.65 Mn |
| Mar 31, 2024 | 22.55 Mn |
| Dec 31, 2023 | 23.25 Mn |
| Sep 30, 2023 | 26.42 Mn |
| Jun 30, 2023 | 19.63 Mn |
| Dec 31, 2022 | 140.19 Mn |
| Dec 31, 2021 | 129.05 Mn |